Table 3.
Mean baseline SF-6D utility values across demographic, comorbid, and clinical characteristics (n=230)
Variables: | Utility Score Mean (SD) |
P-value |
---|---|---|
Age: | ||
18–49* | 0.637 (0.098) | |
50–79 | 0.662 (0.124) | 0.104 |
Gender: | ||
Male | 0.664 (0.121) | |
Female | 0.633 (0.100) | 0.037 |
Study follow-up: | ||
≥ 6 months | 0.619 (0.108) | |
None | 0.661 (0.112) | 0.011 |
Asthma: | ||
Present | 0.657 (0.128) | |
Absent | 0.645 (0.101) | 0.426 |
Nasal polyposis: | ||
Present | 0.668 (0.123) | |
Absent | 0.635 (0.099) | 0.029 |
Allergy: | ||
Present | 0.641 (0.118) | |
Absent | 0.652 (0.110) | 0.503 |
Aspirin intolerance: | ||
Present | 0.679 (0.129) | |
Absent | 0.646 (0.110) | 0.165 |
Depression: | ||
Present | 0.608 (0.098) | |
Absent | 0.658 (0.113) | 0.012 |
Septal deviation | ||
Present | 0.665 (0.110) | |
Absent | 0.643 (0.112) | 0.176 |
History of prior sinus surgery | ||
Yes | 0.643 (0.113) | |
No | 0.659 (0.110) | 0.301 |
Tobacco use | ||
Yes | 0.634 (0.109) | |
No | 0.650 (0.112) | 0.623 |
Alcohol consumption | ||
Yes | 0.661 (0.104) | |
No | 0.640 (0.118) | 0.162 |
age was dichotomized at the median age value for this cohort